Schering-Plough Corp. continues pursuing patent infringement actions against companies seeking approval of generic versions of Clarinex Tablets, Clarinex Reditabs and Clarinex D12.
The Company filed these actions in September 2006. (Lloyds…
Entropic Communications, Inc. is in the process of evaluating Motorola, Inc.’s requests for indemnity and the potential third party claims regarding Motorola’s products that incorporate the Company’s products.
In 2007 and…
A patent infringement action filed by Schering-Plough Corp. and an entity jointly owned with Merck & Co., Inc. against companies seeking approval of a generic version of ZETIA is ongoing.
The…
The case brought by Applied Biosystems Inc. against Illumina, Inc. relating to the ownership of the Macevicz patents is scheduled to go to trial on Dec. 1, 2008.
The Macevicz patents…
Xerox Corp. and MPI Technologies Inc. are considering how to best address the claims that remain as a result of the arbitration panel’s Aug. 28, 2008 decision relating to royalty…
Bristol-Myers Squibb Co. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that on Aug. 12, 2008, the Federal Court of Australia…
Silicon Laboratories Inc., in its Form 10-Q dated Oct. 29, 2008, disclosed that it agreed to dismiss Analog Devices Inc.’s patent and copyright infringement suit in connection with the March…
Several purported antitrust class actions filed in the federal and state courts against Schering-Plough Corp. with regards to the drug, K-DUR, are still ongoing.
Schering-Plough had settled patent litigation with Upsher-Smith,…
A number of suits involving Rambus Inc. are pending in Europe alleging that certain of Micron Technology Inc.’s SDRAM and DDR SDRAM products infringe various of Rambus’ country counterparts.
The suits…
A decision on the post-trial briefing phase for Rambus, Inc.’s spoliation and litigation misconduct claims in Micron Technology Inc.’s complaint is pending.
On Aug. 28, 2000, the Company filed a complaint…